CD4 T CELL DEPENDENT B CELL ACTIVATION IN AIDS LYMPHOMAS
艾滋病淋巴瘤中 CD4 T 细胞依赖性 B 细胞激活
基本信息
- 批准号:2108355
- 负责人:
- 金额:$ 24.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-01 至 1998-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS AIDS related neoplasm /cancer B lymphocyte Epstein Barr virus HIV envelope protein gp120 RNase protection assay SCID mouse antibody receptor cell differentiation clone cells enzyme linked immunosorbent assay genetic strain helper T lymphocyte human immunodeficiency virus 1 leukocyte activation /transformation lymphoma mixed tissue /cell culture neoplastic transformation oncogenes tumor suppressor genes virus antigen
项目摘要
One of the frequent consequences of chronic HIV infection is the
development of AIDS associated lymphomas. These are uniformly high grade
malignancies of B lymphocytes, and they fall into three histological
categories: (i) small, noncleaved cell; (ii) large
immunoblastic/plasmacytoid cell; and (3), large cell lymphoma.
Involvement of Epstein-Barr virus (EBV) is frequently seen in the
immunoblastic tumors, while the other tumor categories show frequent c-
myc rearrangements and mutations of the p53 tumor suppressor gene. While
EBV+ immunoblastic lymphomas have been observed in HIV infection of hu-
PBL-SCID mice, the other AIDS-associated lymphomas have not been seen.
We propose to study the link between HIV infection and chronic B cell
activation, using PBL derived from HIV-infected individuals as well as
normal PBL infected in the context of the hu-PBL-SCID model. The
specific aims of the project are to determine the response of resting,
peripheral blood B cells or tonsillar, germinal center B cells to T cells
or T cell clones infected with HIV or expressing HIV gp120 or gp41. CD4
T cell clones will be chosen on the basis of cytokine production to
represent either the Th0, Th1, or Th2 subset. Selected combinations of
T cell clones and B cells will be introduced into SCID mice to assess the
extent of in vivo B cell proliferation, differentiation, and incidence
of tumor formation. Peripheral blood B cells, tonsilar B cells, and
follicular dendritic cells will be derived from normal donors and PBL
from normal and HIV-seropositive donors. EBV seropositive donors who do
not give rise to spontaneous tumors will be used. We will also examine
expression of B cell genes that might block apoptosis and represent the
first step towards malignant transformation under the differing
conditions of T cell stimulation outlined in Aim 1. Expression of bcl-2
and the Epstein-Barr virus genes LMP (which transactivates bcl-2
expression), EBNA-2, and ZEBRA will be analyzed by a sensitive RNase
protection assay. PBL and germinal center B cells from EBV-positive and
EBV-negative donors will be compared. Finally, we will determine the
relationship between different HIV-1 strains and specific activation of
B cells expressing the VH3 immunoglobulin variable region. Preliminary
evidence shows a correlation between the HIV strain used to infect hu-
PBL-SCID mice, the rate of CD4 T cell depletion, and the extent of VH3
B cell stimulation. These data suggest that different gp120 molecules
may interact differently with the Ig receptor on VH3-expressing B cells,
and/or that the extent of CD4 T cell activation following HIV infection
differs markedly among different virus strains.
慢性艾滋病毒感染的常见后果之一是
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Epstein-Barr virus and lymphoproliferative disease.
Epstein-Barr 病毒和淋巴组织增生性疾病。
- DOI:10.1097/00062752-199901000-00005
- 发表时间:1999
- 期刊:
- 影响因子:0
- 作者:Mosier,DE
- 通讯作者:Mosier,DE
Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co‐infection
存在或不存在人类免疫缺陷病毒(HIV)合并感染的阿根廷血友病患者中丙型肝炎(HCV)基因型和病毒滴度分布
- DOI:
- 发表时间:1997
- 期刊:
- 影响因子:12.7
- 作者:G. Picchio;M. Nakatsuno;C. Boggiano;Rebecca Sabbe;M. Corti;J. Daruich;R. PÉREZ‐BIANCO;M. Tezanos;Robert Kokka;J. Wilber;D. Mosier
- 通讯作者:D. Mosier
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD E MOSIER其他文献
DONALD E MOSIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD E MOSIER', 18)}}的其他基金
Modeling HIV-1 primary transmission in vitro and in vivo
HIV-1 初次传播的体外和体内建模
- 批准号:
8434156 - 财政年份:2011
- 资助金额:
$ 24.92万 - 项目类别:
Modeling HIV-1 primary transmission in vitro and in vivo
HIV-1 初次传播的体外和体内建模
- 批准号:
8238279 - 财政年份:2011
- 资助金额:
$ 24.92万 - 项目类别:
Modeling HIV-1 primary transmission in vitro and in vivo
HIV-1 初次传播的体外和体内建模
- 批准号:
8627538 - 财政年份:2011
- 资助金额:
$ 24.92万 - 项目类别:
Modeling HIV-1 primary transmission in vitro and in vivo
HIV-1 初次传播的体外和体内建模
- 批准号:
8113111 - 财政年份:2011
- 资助金额:
$ 24.92万 - 项目类别:
Cross-reactive HERV immunity to combat HIV-1 infection
交叉反应性 HERV 免疫对抗 HIV-1 感染
- 批准号:
7914339 - 财政年份:2009
- 资助金额:
$ 24.92万 - 项目类别:
Cross-reactive HERV immunity to combat HIV-1 infection
交叉反应性 HERV 免疫对抗 HIV-1 感染
- 批准号:
7737332 - 财政年份:2009
- 资助金额:
$ 24.92万 - 项目类别:
Improved Humanized Mouse Models for Vaccine Development
用于疫苗开发的改进人源化小鼠模型
- 批准号:
7689165 - 财政年份:2008
- 资助金额:
$ 24.92万 - 项目类别: